Home > product > Ohter Rx
 
Reaferon is a recombinant interferon α-2b treating hepatitis and cancer
Reaferon exerts complex antiviral, immunomodulatory, and antiproliferative actions.


1vial contains interferon α-2b 3X106 IU/mL
(Host : Psudomonas putida, Vector : pVG3)

① Acute hepatitis B
② Improvement of viremia of chronic active hepatitis B in HBV-DNA positive
③ Chronic hepatitis C
④ Chronic myelogenous leukemia
⑤ Renal cancer


① Acute hepatitis B : 1X106 IU, twice a day for 5-6 days by IM injection.Then once a day for 5 days.
② Chronic active hepatitis B in HBV-DNA positive : 3-6X106 IU, 3 times a week.
③ Chronic hepatitis C : 3X106 IU, 3 times a week.
④ Chronic myelogenous leukemia:9X106 IU everyday.
⑤ Renal cell carcinoma: 18X106 IU, 3 times a week.


1. Reaferon is a recombinant interferon produced using non-pathogenic host, Psudomonas putida.
2. Reaferon has the identical amino acid sequence to the natural amino acid sequence.
3. Manufacturing technique of Reaferon got a patent in the USA in 1987.